Gland Pharma consolidated net profit rises 33.69% in the March 2021 quarter

Sales rise 39.75% to Rs 887.75 crore

Net profit of Gland Pharma rose 33.69% to Rs 260.41 crore in the quarter ended March 2021 as against Rs 194.79 crore during the previous quarter ended March 2020. Sales rose 39.75% to Rs 887.75 crore in the quarter ended March 2021 as against Rs 635.24 crore during the previous quarter ended March 2020.

For the full year,net profit rose 29.00% to Rs 996.96 crore in the year ended March 2021 as against Rs 772.86 crore during the previous year ended March 2020. Sales rose 31.51% to Rs 3462.88 crore in the year ended March 2021 as against Rs 2633.24 crore during the previous year ended March 2020.

 

ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales887.75635.24 40 3462.882633.24 32 OPM %36.9137.76 -37.6136.28 - PBDT373.87285.59 31 1433.591087.45 32 PBT348.94261.51 33 1334.81992.87 34 NP260.41194.79 34 996.96772.86 29

Powered by Capital Market - Live News